EUCTR2018-001328-21-NL进行中（未招募）1 期
Chronotherapy with aspirin for reduction of cardiovascular disease - TImE ASPIRI
eiden University Medical Center0 个研究点目标入组 4,000 人开始时间: 2019年1月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 4,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patients who already use low-dose aspirin for secondary prevention of cardiovascular events and use a multidose drug dispensing
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1000
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 3000
排除标准
- •Insufficient knowledge of the Dutch language
- •Patients currently participating in another (clinical) trial or study
研究者
相似试验
已完成
4 期
Chronotherapy with aspirin for reduction of cardiovascular diseasecardiovasculaire aandoeningencardiovascular diseases10011082NL-OMON55498eids Universitair Medisch Centrum328
招募中
1 期
Aspirin to prevent cardiovascular events in patients with pneumoniaPneumonia, Myocardial infarctionCTIS2023-504553-12-01Amsterdam UMC760
终止
不适用
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular DiseaseCardiovascular DiseasesNCT04132791Leiden University Medical Center328
已完成
不适用
Effects of aspirin for primary prevention of ASCVDs in DM type2 patientsCardiovascular Event in Type 2 diabetes patientsCardiovascular disease, Primary prevention, Aspirin, Type 2 diabetesTCTR20240328011one682
进行中（未招募）
4 期
Chronotherapy with Low-dose Aspirin for Primary PreventionType 2 DiabetesNCT00725127University of Vigo3,200